Jonathan B. Perlin, MD, PhD

President, Clinical Services Group and Chief Medical Officer
HCA Healthcare
Nashville, Tennessee, United States

Medline (Other Financial or Material Support, Conducted studies in which participating hospitals received contributed antiseptic product)Molnlycke (Other Financial or Material Support, Conducted studies in which participating hospitals received contributed antiseptic product)

Presentation(s):

• 4 - 137 Hospital Cluster-Randomized Trial of Mupirocin-Chlorhexidine vs Iodophor-Chlorhexidine for Universal Decolonization in Intensive Care Units (ICUs) (Mupirocin Iodophor Swap Out Trial)

  On Demand

• 13 - INSPIRE-ASP Pneumonia Trial: A 59 Hospital Cluster Randomized Evaluation of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Pneumonia

  On Demand

• 171 - The Impact of COVID-19 on Healthcare-Associated Infections

  On Demand